| Dr Daniel Jeremy Waintraub, MD | |
|
7200 Camino Real Ste 300, Boca Raton, FL 33433-5511 | |
| (561) 487-4110 | |
| Not Available |
| Full Name | Dr Daniel Jeremy Waintraub |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 11 Years |
| Location | 7200 Camino Real Ste 300, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750624037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | ME142523 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Boca Medical Center | Boca raton, FL | Hospital |
| Boca Raton Regional Hospital | Boca raton, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastro Health, Llc | 2365440567 | 236 |
News Archive
The safety of cosmetic surgery has again become an issue following the death of the mother of rapper Kanye West.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy.
Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that additional claims for the patent family "Method and kit for imaging and treating organs and tissue," were issued as U.S. Patent No. 7,811,570.
Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy.
› Verified 2 days ago
| Entity Name | Gastro Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487767133 PECOS PAC ID: 2365440567 Enrollment ID: O20061127000011 |
News Archive
The safety of cosmetic surgery has again become an issue following the death of the mother of rapper Kanye West.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy.
Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that additional claims for the patent family "Method and kit for imaging and treating organs and tissue," were issued as U.S. Patent No. 7,811,570.
Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy.
› Verified 2 days ago
| Entity Name | Moshe E Hirth Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710150495 PECOS PAC ID: 2961580535 Enrollment ID: O20080422000858 |
News Archive
The safety of cosmetic surgery has again become an issue following the death of the mother of rapper Kanye West.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy.
Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that additional claims for the patent family "Method and kit for imaging and treating organs and tissue," were issued as U.S. Patent No. 7,811,570.
Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Jeremy Waintraub, MD 7200 Camino Real Ste 300, Boca Raton, FL 33433-5511 Ph: (561) 487-4110 | Dr Daniel Jeremy Waintraub, MD 7200 Camino Real Ste 300, Boca Raton, FL 33433-5511 Ph: (561) 487-4110 |
News Archive
The safety of cosmetic surgery has again become an issue following the death of the mother of rapper Kanye West.
BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the company's collaboration with Merck Serono, the biopharmaceutical division of Merck, Darmstadt, Germany, for BGB-283, a second-generation BRAF inhibitor candidate currently in Phase 1 development.
Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy.
Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that additional claims for the patent family "Method and kit for imaging and treating organs and tissue," were issued as U.S. Patent No. 7,811,570.
Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy.
› Verified 2 days ago
Dr. Craig Michael Brodsky, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1000 Nw 9th Ct, Suite 201, Boca Raton, FL 33486 Phone: 561-395-4600 Fax: 561-395-6903 | |
Dr. Sandra Luz Hirsch, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 660 Glades Rd, Ste 300, Boca Raton, FL 33431 Phone: 561-620-8992 Fax: 561-620-5815 | |
Dr. David John Alley, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 660 Glades Rd, Suite 140, Boca Raton, FL 33431 Phone: 561-447-7737 Fax: 561-447-9022 | |
Mrs. Mushfeka Moiz Golawala, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20384 Hacienda Ct, Boca Raton, FL 33498 Phone: 561-703-1383 Fax: 561-423-8372 | |
Mohamed Atef Mohamed Elmahdy Hamed, Gastroenterology Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-7100 | |
Craig L Stemmer, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2900 N Military Trl, Ste 195, Boca Raton, FL 33431 Phone: 561-241-7100 Fax: 561-241-3647 | |
Farid Assouad, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7777 Glades Rd, Ste 100, Boca Raton, FL 33434 Phone: 561-573-3495 Fax: 888-910-3040 |